2015
DOI: 10.1016/bs.seda.2015.05.006
|View full text |Cite
|
Sign up to set email alerts
|

Insulin, Other Hypoglycemic Drugs, and Glucagon

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 73 publications
0
1
0
Order By: Relevance
“…The insulin analogues later approved for human use were aspart insulin (NovoRapid), glargine insulin (Lantus), glulisine insulin (Apidra), detemir insulin (Levemir) and inhalable insulin, Exubera & Afrezza, in 2000, 2000, 2004, 2005, 2006 and 2014 respectively [ 104 ]. "Degludec Insulin" was withdrawn from the market in 2013 for severe side-effects with other drugs, but in 2015 it was again allowed to use with some changes in its composition [ 39 ].…”
Section: History Of the Discovery Of Insulinmentioning
confidence: 99%
“…The insulin analogues later approved for human use were aspart insulin (NovoRapid), glargine insulin (Lantus), glulisine insulin (Apidra), detemir insulin (Levemir) and inhalable insulin, Exubera & Afrezza, in 2000, 2000, 2004, 2005, 2006 and 2014 respectively [ 104 ]. "Degludec Insulin" was withdrawn from the market in 2013 for severe side-effects with other drugs, but in 2015 it was again allowed to use with some changes in its composition [ 39 ].…”
Section: History Of the Discovery Of Insulinmentioning
confidence: 99%